HIMSS expands to gaming community

The Personal Connected Health Alliance (PCHA) at HIMSS and the Games for Health Project have launched a strategic partnership to deliver comprehensive resources and business development opportunities to the gaming community. HIMSS and PCHA are focusing on advancing personal health technologies in care delivery, including mobile and connected health, that empower and engage providers, patients and consumers in health and wellness, according to a release.

“Gaming technology is playing an increasing role in care delivery and the management of health and wellness,” said Richard Scarfo, vice president of PCHA and director of the mHealth Summit. “Our strategic partnership with Games for Health compliments PCHA’s support of the full continuum of technology-driven health and wellness. Gaming technology is becoming an important addition to social media, wearables and mobile health, as well as an adjunct to clinical care management.”

As part of this collaboration, Games for Health will host a portfolio of activities at both this year’s mHealth Summit and the HIMSS16 Annual Conference. The Games for Health University will once again return to the 2015 mHealth Summit on November 8, featuring a full-day tutorial focused on how and when games should be used in the health and healthcare sectors. The Games for Health annual meeting, also taking place at the summit, will cover topics including exergaming, physical therapy, disease management, health behavior change, biofeedback, rehab, epidemiology, training, cognitive health, nutrition and health education. 

The Games for Health Project supports community, knowledge and business development efforts to use cutting-edge games and game technologies to improve health and healthcare. The Robert Wood Johnson Foundation is the original sponsor and remains a major supporter of Games for Health.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.